APA (7th ed.) Citation

BA, D., J, C., A, P., H, S., T, K., J, Z., . . . AJ, J. (2025). Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet-treated multiple myeloma without transplant. HemaSphere, 9(8), e70186. https://doi.org/10.1002/hem3.70186

Chicago Style (17th ed.) Citation

BA, Derman, et al. "Early Peripheral Blood and Bone Marrow MRD as Prognostic Markers in Quadruplet-treated Multiple Myeloma Without Transplant." HemaSphere 9, no. 8 (2025): e70186. https://doi.org/10.1002/hem3.70186.

MLA (9th ed.) Citation

BA, Derman, et al. "Early Peripheral Blood and Bone Marrow MRD as Prognostic Markers in Quadruplet-treated Multiple Myeloma Without Transplant." HemaSphere, vol. 9, no. 8, 2025, p. e70186, https://doi.org/10.1002/hem3.70186.